Weight gain that appears without any change in diet or activity is one of the most frustrating and demoralising experiences in hormonal disruption, because it contradicts the logic most people apply to their bodies: eat the same, move the same, weigh the same. But weight and body composition are not governed only by caloric input and output. They are governed by the hormonal environment that determines how calories are stored, where fat is deposited, how much water is retained, how efficiently the thyroid drives metabolism, and how effectively the body responds to insulin. When that hormonal environment is significantly disrupted by chronic stress, each of those mechanisms shifts in directions that produce weight gain or body composition changes independent of any change in diet or activity.
Stop applying caloric restriction logic to a hormonal problem. Reducing food intake further in the context of cortisol elevation typically worsens the hormonal picture, increases cortisol, and compounds the weight gain rather than resolving it.
The weight changes associated with hormonal disruption are driven by cortisol-induced fat storage signals, insulin resistance, fluid retention from estrogen dominance, and thyroid conversion impairment, none of which respond to caloric restriction the way dietary-origin weight gain does.
Functional testing that includes a cortisol diurnal panel, fasting insulin, thyroid markers (including T3 and reverse T3), and the Pg/E2 ratio gives a working picture of which hormonal mechanisms are most active and what needs to be addressed to change the body composition picture.
The most direct hormonal mechanism connecting chronic stress to weight gain is cortisol's effect on fat storage, specifically in the abdominal region.
Visceral adipose tissue (the fat stored around the organs in the abdominal cavity) has a higher density of cortisol receptors than any other fat depot in the body. This means it is disproportionately responsive to cortisol signals. When cortisol is chronically elevated, the fat storage signal at this depot is continuously activated: the body preferentially directs available energy toward visceral fat storage, and it preferentially preserves that fat against mobilisation, because the cortisol signal is interpreted as a resource-scarcity environment requiring energy reserves to be maintained.
This produces a specific pattern: midsection weight gain that is disproportionate to changes in total body weight, and that is resistant to the approaches that work for dietary-origin fat gain. The weight is not there because of excess caloric intake. It is there because the hormonal environment is signalling the body to store and preserve energy centrally, regardless of actual energy availability. This mechanism operates independent of diet and activity, which is why the frustrating experience of gaining weight around the middle while eating and exercising as normal is so common in populations under sustained occupational stress.
The cortisol-visceral fat relationship is also bidirectional: visceral fat itself produces inflammatory compounds that further activate the cortisol system, creating a compounding cycle in which cortisol-driven fat storage generates additional cortisol activation.
The second major mechanism is insulin resistance, which develops through both cortisol elevation and sleep disruption and produces weight-gain-relevant metabolic changes independent of dietary intake.
Cortisol promotes insulin resistance by mobilising glucose into the bloodstream (an acute adaptive response) and by reducing cellular insulin sensitivity over time. When cells become less responsive to insulin's signal to take up glucose, blood glucose remains elevated for longer after meals, and the pancreas compensates by producing more insulin. Elevated insulin is a potent fat storage signal: it promotes the conversion of excess blood glucose to fat and inhibits the breakdown of stored fat for energy use. The result is a metabolic environment in which more of the available energy is directed toward storage and less toward utilisation, producing a net gain in fat mass without any increase in caloric intake.
Sleep disruption compounds this. Research consistently shows that even one week of reduced sleep measurably reduces insulin sensitivity in otherwise healthy individuals, producing the same metabolic shift toward storage over utilisation that cortisol drives through separate but converging mechanisms.
For crew in active seasons, managing both sustained cortisol elevation and fragmented sleep simultaneously means both mechanisms are operating at once, producing a combined insulin-resistance effect that is larger than either would produce alone, and that manifests as unexplained body composition changes even in the presence of a stable diet and activity level.
Not all of the weight change associated with hormonal disruption in women is fat gain. A significant proportion is fluid retention driven by the estrogen dominance pattern, and understanding the distinction matters because it responds to different interventions.
Estrogen promotes fluid retention directly through its effect on aldosterone (a hormone that governs sodium and water balance) and on the permeability of blood vessels. In the luteal phase and in sustained estrogen dominance patterns, this fluid retention produces the puffiness, bloating, and weight fluctuation that many women notice across the cycle and during demanding seasons. This is not fat gain in the conventional sense. It is a genuine increase in body water that can represent several kilograms of weight variation and that responds to hormonal rebalancing rather than dietary restriction.
The fat distribution changes associated with estrogen dominance are distinct from the visceral fat driven by cortisol. Estrogen-sensitive fat depots are primarily in the hips, thighs, and lower abdomen rather than the deep abdominal area, reflecting the different receptor distribution of these two hormonal drivers. Women with a combination of cortisol-driven visceral gain and estrogen-dominant peripheral gain may experience both simultaneously, producing a body composition change that looks like generalised weight gain but has two different hormonal mechanisms requiring two different parts of the same upstream intervention.
A third mechanism that contributes to unexplained weight gain, and is frequently missed in standard healthcare assessment, is the effect of chronic cortisol elevation on thyroid hormone conversion.
The thyroid gland produces primarily T4, an inactive precursor that must be converted to T3 (the biologically active form) in the liver, gut, and other peripheral tissues to drive metabolic rate, energy production, and thermogenesis. Chronically elevated cortisol suppresses this T4-to-T3 conversion, and can also drive increased production of reverse T3 (rT3), an inactive form that occupies T3 receptors without activating them, effectively blocking T3's metabolic effects even when T3 production appears adequate.
The result is a functional reduction in metabolic rate: the thyroid gland is producing T4 normally (which is why TSH may appear normal on standard testing), but less of that T4 is being converted to the active T3 that drives metabolism. This produces the classic signs of functional hypothyroidism, including slowed metabolism, difficulty losing weight, cold sensitivity, fatigue, and hair changes, in the presence of a thyroid gland that technically appears to be functioning normally on standard testing.
For crew who have been gaining weight and experiencing unexplained fatigue and cold sensitivity without any change in diet or activity, and whose standard thyroid testing (TSH alone) has returned normal, this conversion impairment is worth investigating through a functional thyroid panel that includes T3 and reverse T3 alongside TSH and T4.
The fifth mechanism contributing to weight changes in the context of disrupted sleep and chronic stress is the dysregulation of leptin and ghrelin, the hormones that govern appetite, satiety, and hunger signalling.
Leptin is produced by fat cells and signals satiety to the brain: adequate leptin tells the body that energy stores are sufficient and reduces appetite. Ghrelin is produced by the stomach and signals hunger: elevated ghrelin increases appetite and promotes food-seeking behaviour. Sleep deprivation reduces leptin and increases ghrelin simultaneously, producing a combined increase in appetite and reduction in satiety signalling that drives greater food intake even in the absence of actual increased caloric need.
Chronic cortisol elevation also increases appetite directly through its effects on the reward pathways that drive food-seeking behaviour, with a particular tendency toward calorie-dense, carbohydrate-rich foods, which is part of why stress-driven food cravings are a measurable physiological response rather than simply a psychological habit.
For crew eating in a chef-controlled environment where portion control and food selection are not directly within their control, this hormonally amplified hunger signal can produce increased intake that is genuinely invisible from the inside, because it does not feel like overeating. It feels like normal hunger, because the hormonal system is reporting normal hunger while the body's actual energy needs have not increased.
My most recent functional panel, run in July 2025, included a fasting insulin measurement of 5.4. That number sits above the optimal range, even though it is within the standard reference range that most conventional testing uses. This distinction, between optimal and standard reference ranges, is one of the central concepts in functional medicine, and it is directly relevant to the weight and body composition picture.
A fasting insulin above optimal indicates early insulin resistance: cells are already becoming less responsive to insulin's signal, meaning glucose is being cleared from the blood less efficiently and the storage signal is elevated relative to what a fully insulin-sensitive system would produce. This is not a dramatic pathological finding. It is an early-stage metabolic shift that is entirely consistent with the sustained cortisol load shown in my cortisol panels and the sleep disruption that has been a recurring feature of demanding seasons.
What I take from this is not alarm but a clear explanation for a body composition pattern that many people in this industry recognise: the feeling that things are shifting in ways that don't correlate with any change in eating or activity. They are right that nothing obvious has changed. What has changed is the metabolic environment determining what the body does with the food it receives, and that environment is governed by the hormonal picture, not by the caloric equation alone.
This is why I emphasise testing rather than dietary restriction as the first response to unexplained weight changes. The number tells you what is actually happening. And knowing what is actually happening, rather than assuming the answer is simply eating less, is what makes the intervention appropriate to the actual cause.
Addressing the hormonal pattern generally produces meaningful improvement in body composition, though the timeline and degree vary. The fluid retention component of estrogen dominance can resolve relatively quickly (within one to two months) once the Pg/E2 ratio improves. The cortisol-driven visceral fat component tends to reduce more gradually over three to six months as cortisol patterns normalise. The insulin resistance component responds to both hormonal rebalancing and supporting dietary changes. Weight loss is rarely the primary goal of hormonal intervention, but body composition improvement is a consistent secondary outcome.
Generally not, and particularly not as a first response. Caloric restriction in the context of elevated cortisol typically increases cortisol further, because the body interprets reduced energy availability as an additional stressor. This worsens the hormonal picture and often produces the paradoxical effect of more fat storage rather than less. Ensuring adequate caloric intake, particularly of protein and healthy fats that support hormone production, is usually more important than restriction when the underlying cause is hormonal disruption rather than dietary excess.
Yes, in two relevant ways. First, cortisol-driven visceral fat is located deeper in the abdominal cavity (around the organs) rather than as subcutaneous fat directly under the skin. Second, it is more metabolically active and more strongly associated with inflammatory and cardiometabolic risk than subcutaneous abdominal fat. Practically, it tends to be more resistant to dietary changes than subcutaneous fat and responds more directly to cortisol reduction than to caloric approaches.
Yes, noticeably so. Hormonal fluid retention can account for two to four kilograms of weight variation in some women, particularly in the premenstrual phase or during periods of sustained estrogen dominance. This weight fluctuates significantly (often appearing or worsening premenstrually and reducing after menstruation), does not feel like hard body mass in the way fat does, and responds to addressing the hormonal pattern rather than to dietary restriction. If weight fluctuates significantly across the cycle without any dietary change, fluid retention from estrogen dominance is the most likely explanation.
Yes, if the testing only included TSH. The T4-to-T3 conversion impairment described in this article operates downstream of the thyroid gland itself, which means TSH (the pituitary signal to the thyroid) can appear normal while the active thyroid hormone reaching cells is suboptimal. A functional thyroid panel that includes free T3, free T4, and reverse T3 alongside TSH gives a more complete picture of whether the conversion step is functioning adequately. This is one of the most common gaps in standard thyroid assessment for people under sustained occupational stress.
Partially, for most people. A genuine recovery period with restored sleep, reduced cortisol demand, and consistent eating patterns typically produces measurable improvement in insulin sensitivity and gradual reduction in visceral fat over two to four months. However, if the hormonal disruption has been sustained for multiple seasons, the accumulated pattern (particularly the insulin resistance and thyroid conversion impairment) may need more targeted support to fully resolve than rest alone provides. Testing during a recovery period, rather than assuming rest will be sufficient, gives the most accurate picture of what has genuinely normalised and what still needs support.
The Crew Vitality Method combines at-home functional lab testing with personalized protocols built for the realities of life in yachting.